Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stem cell shot aims to restore ovarian function in small safety trial

NCT ID NCT06578039

First seen Nov 19, 2025 · Last updated May 13, 2026 · Updated 25 times

Summary

This early-stage study tested the safety of a single injection of stem cells from donated umbilical cords in 6 women with premature ovarian insufficiency (early menopause). The main goal was to see if the treatment is safe and to find the best dose. Researchers also checked for changes in hormone levels that might suggest the ovaries are working again.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE OVARIAN INSUFFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHA Bundang Medical Center

    Seongnam-si, Gyeonggi-do, 463-712, South Korea

Conditions

Explore the condition pages connected to this study.